Ascent Bio
PrivateLast Round
Accelerator
Nov 30, 2023
Total Funding Raised
$150,000
Company Overview
Ascent Bio is a software company that develops an autonomous artificial intelligence platform for drug design and molecular optimization.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ascent Bio Comparables
Compare Ascent Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TandemAI | 78% | |
| Receptor.AI | 77% | |
| Alphabet Inc. | 77% |
Ascent Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Nov 30, 2023 |
Ascent Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Merck Digital Sciences Studio | Accelerator |
| Nucleate | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 25, 2024
Grew 100% QoQ from 3 to 6 employees.
Ascent Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ascent Bio's valuation, stock price, and market status.
Is Ascent Bio a public or private company?
Ascent Bio is a private company.
What is the current stock price of Ascent Bio?
Ascent Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Ascent Bio worth (valuation)?
Valuation information for Ascent Bio is not publicly available.
Can I buy Ascent Bio stock?
Ascent Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ascent Bio's last funding round?
Ascent Bio's most recent funding round was Accelerator on November 30, 2023.
Who are the main investors in Ascent Bio?
Key investors in Ascent Bio include Merck Digital Sciences Studio, Nucleate.
Will Ascent Bio IPO soon?
No public IPO plans have been announced for Ascent Bio.
How can I track Ascent Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ascent Bio's secondary market activity and sign up for updates.